Skip to content
WeighLab
Menu
Ranked #124 · Grade C

Kin Meds review

Kin Meds is a LegitScript-verified telehealth platform offering both compounded GLP-1s (semaglutide from $199/mo, tirzepatide from $249/mo) and brand-name FDA-approved options including Wegovy injection and…

Visit Kin Meds Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. See our disclosure.
Semaglutide
$149/mo (brand Wegovy)
Tirzepatide
$149/mo (brand Zepbound)
Coverage
Coverage not published
Brand-name
Yes

Semaglutide · modeled / year

$1,788

Tirzepatide · modeled / year

$1,788

The Index scorecard

Kin Meds scored on our six Cost-Efficiency Index factors. See the methodology.

Normalized Cost/Month81/100
Price Transparency78/100
Nationwide Access24/100
Formulation Options95/100
Clinical Oversight74/100
Contract Flexibility55/100

Where the value is

  • Publicly lists $199/mo compounded semaglutide and $249/mo compounded tirzepatide
  • Brand-name options too — Wegovy injection and pill, Zepbound, Foundayo from $149/mo entry pricing
  • LegitScript verified
  • Clearly identifies itself as the intake platform and a licensed third-party pharmacy as the dispenser
  • Broad longevity menu (Sermorelin, NAD+, Glutathione) plus TRT, hair, skin, and sexual health

The tradeoffs

  • Legal entity name and state of incorporation not publicly disclosed
  • The third-party pharmacy partner isn't named, and Kin Meds isn't itself a licensed pharmacy
  • Per-state availability not listed
  • $149/mo brand pricing is the insured entry tier — cash-pay patients should expect higher real costs
  • Lab work and dose-titration support not clearly described

The bottom line

Best for: Cost-first shoppers who want compounded and brand-name GLP-1 plus a longevity stack on one platform. Kin Meds is a LegitScript-verified telehealth platform offering both compounded GLP-1s (semaglutide from $199/mo, tirzepatide from $249/mo) and brand-name FDA-approved options including Wegovy injection and…

Ranked #124 of 492 providers on the Cost-Efficiency Index — see our #1 pick, CoreAge Rx, for comparison.

Compare with other providers

All 491 other providers we've modeled, in Cost-Efficiency Index order. See the ranked alternatives to Kin Meds.

The 18 programs nearest this one

Pricing, states and verification reflect Kin Meds's public disclosures at last review; the Cost-Efficiency Index is our editorial judgment per the methodology. Prices change — confirm on Kin Meds's site. Not medical advice; see our disclosure.

← Back to the value leaderboard